Prediction of fetal hemoglobin in sickle cell anemia using an ensemble of genetic risk prediction models

Circulation: Cardiovascular Genetics

Volumn 7, Issue 2, 2014, Pages 110-115

  Milton, Jacqueline N ^a   Gordeuk, Victor R ^b   Taylor, James G ^c   Gladwin, Mark T ^d   Steinberg, Martin H ^e   Sebastiani, Paola ^a  

^a BOSTON UNIVERSITY   (United States)

^b HOWARD UNIVERSITY   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anemia; Genetic association studies; Genetics; Hemoglobins; Risk factors; Sickle cell

Indexed keywords

HEMOGLOBIN F; SPACER DNA;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; FEMALE; GENE CLUSTER; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SCHOOL CHILD; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; ANEMIA, SICKLE CELL; BIOLOGICAL MODEL; COHORT ANALYSIS; GENETIC VARIATION; GENETICS; METABOLISM; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FETAL HEMOGLOBIN; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84903649037     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.113.000387     Document Type: Article

References (50)

1. Steinberg MH, Nagel RL, Forget BG, Higgs DR, Weatherall DJ. Genetic modulation of sickle cell disease and thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Weatherall DJ, eds. Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management. Cambridge: Cambridge University Press; 2009:638-657.
2. Solovieff N, Milton JN, Hartley SW, Sherva R, Sebastiani P, Dworkis DA, et al. Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster. Blood. 2010;115:1815-1822.
3. Steinberg MH, Sebastiani P. Genetic modifiers of sickle cell disease. Am J Hematol. 2012;87:795-803.
4. Steinberg MH, Hsu H, Nagel RL, Milner PF, Adams JG, Benjamin L, et al. Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia. Am J Hematol. 1995;48:175-181.
5. Garner C, Tatu T, Reittie JE, Littlewood T, Darley J, Cervino S, et al. Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood. 2000;95:342-346. (Pubitemid 30017262)
6. Menzel S, Thein SL. Genetic architecture of hemoglobin F control. Curr Opin Hematol. 2009;16:179-186.
7. Bae HT, Baldwin CT, Sebastiani P, Telen MJ, Ashley-Koch A, Garrett M, et al. Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L- MYB are the major modifiers of HbF in African Americans. Blood. 2012;120:1961-1962.
8. Gibson G. Rare and common variants: twenty arguments. Nat Rev Genet. 2011;13:135-145.
9. Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, Dupuis J, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008;359:2208-2219.
10. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748-752.
11. Paynter NP, Chasman DI, Paré G, Buring JE, Cook NR, Miletich JP, et al. Association between a literature-based genetic risk score and cardiovascular events in women. JAMA. 2010;303:631-637.
12. Sebastiani P, Solovieff N, Sun JX. Naïve Bayesian classifier and genetic risk score for genetic risk prediction of a categorical trait: not so different after all! Front Genet. 2012;3:26.
13. Sebastiani P, Solovieff N, Dewan AT, Walsh KM, Puca A, Hartley SW, et al. Genetic signatures of exceptional longevity in humans. PLoS One. 2012;7:e29848.
14. Gaston M, Rosse WF. The cooperative study of sickle cell disease: review of study design and objectives. Am J Pediatr Hematol Oncol. 1982;4:197-201. (Pubitemid 12017322)
15. Dham N, Ensing G, Minniti C, Campbell A, Arteta M, Rana S, et al. Prospective echocardiography assessment of pulmonary hypertension and its potential etiologies in children with sickle cell disease. Am J Cardiol. 2009;104:713-720.
16. Machado RF, Barst RJ, Yovetich NA, Hassell KL, Kato GJ, Gordeuk VR, et al Walk-PHaSST Investigators and Patients. Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity. Blood. 2011;118:855-864.
17. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population- based linkage analyses. Am J Hum Genet. 2007;81:559-575. (Pubitemid 47330214)
18. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38:904-909. (Pubitemid 44141658)
19. Breiman L. Bagging predictors. Machine Learning. 1996;24:123-140. (Pubitemid 126724382)
20. Mevik B-H, Segtnan VH, Næs T. Ensemble methods and partial least squares regression. J Chemom. 2004;18:498-507. (Pubitemid 40688863)
21. Rokach L. Ensembled-based classifiers. Art Intell Review. 2010;33:1-39.
22. Sedgewick AE, Timofeev N, Sebastiani P, So JC, Ma ES, Chan LC, et al. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies. Blood Cells Mol Dis. 2008;41:255-258.
23. Uda M, Galanello R, Sanna S, Lettre G, Sankaran VG, Chen W, et al. Genome- wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta- thalassemia. Proc Natl Acad Sci U S A. 2008;105:1620-1625. (Pubitemid 351346564)
24. Pilia G, Chen WM, Scuteri A, Orrú M, Albai G, Dei M, et al. Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet. 2006;2:e132.
25. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A. 2009;106:9362-9367.
26. Galarneau G, Palmer CD, Sankaran VG, Orkin SH, Hirschhorn JN, Lettre G. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat Genet. 2010;42:1049-1051.
27. West MS, Wethers D, Smith J, Steinberg M; The Cooperative Study of Sickle Cell Disease. Laboratory profile of sickle cell disease: a crosssectional analysis. J Clin Epidemiol. 1992;45:893-909.
28. Morris J, Dunn D, Beckford M, Grandison Y, Mason K, Higgs D, et al. The haematology of homozygous sickle cell disease after the age of 40 years. Br J Haematol. 1991;77:382-385.
29. Hayes RJ, Beckford M, Grandison Y, Mason K, Serjeant BE, Serjeant GR. The haematology of steady state homozygous sickle cell disease: frequency distributions, variation with age and sex, longitudinal observations. Br J Haematol. 1985;59:369-382. (Pubitemid 15151608)
30. Sankaran VG, Menne TF, Xu J, Akie TE, Lettre G, Van Handel B, et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science. 2008;322:1839-1842.
31. Chen Z, Luo HY, Steinberg MH, Chui DH. BCL11A represses HBG transcription in K562 cells. Blood Cells Mol Dis. 2009;42:144-149.
32. Feingold EA, Penny LA, Nienhuis AW, Forget BG. An olfactory receptor gene is located in the extended human beta-globin gene cluster and is expressed in erythroid cells. Genomics. 1999;61:15-23. (Pubitemid 29487617)
33. Hughes MF, Saarela O, Stritzke J, Kee F, Silander K, Klopp N, et al. Genetic markers enhance coronary risk prediction in men: the MORGAM prospective cohorts. PLoS One. 2012;7:e40922.
34. Onuki R, Shibuya T, Kanehisa M. New kernel methods for phenotype prediction from genotype data. Genome Inform. 2010;22:132-141.
35. Wei Z, Wang K, Qu HQ, Zhang H, Bradfield J, Kim C, et al. From disease association to risk assessment: an optimistic view from genome-wide association studies on type 1 diabetes. PLoS Genet. 2009;5:e1000678.
36. Wu C, Walsh KM, Dewan AT, Hoh J, Wang Z. Disease risk prediction with rare and common variants. BMC Proc. 2011;5(suppl 9):S61.
37. Moore JH, Gilbert JC, Tsai CT, Chiang FT, Holden T, Barney N, et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol. 2006;241:252-261. (Pubitemid 43993963)
38. Rodin AS, Boerwinkle E. Mining genetic epidemiology data with Bayesian networks I: Bayesian networks and example application (plasma apoE levels). Bioinformatics. 2005;21:3273-3278. (Pubitemid 41418441)
39. Sebastiani P, Ramoni MF, Nolan V, Baldwin CT, Steinberg MH. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet. 2005;37:435-440.
40. Jiang X, Barmada MM, Cooper GF, Becich MJ. A bayesian method for evaluating and discovering disease loci associations. PLoS One. 2011;6:e22075.
41. Kang J, Zheng W, Li L, Lee JS, Yan X, Zhao H. Use of Bayesian networks to dissect the complexity of genetic disease: application to the Genetic Analysis Workshop 17 simulated data. BMC Proc. 2011;5(suppl 9):S37.
42. Sebastiani P, Perls TT. Prediction models that include genetic data. Circ Cardiovasc Genet. 2010;3:1-2.
43. Hartley SW, Monti S, Liu CT, Steinberg MH, Sebastiani P. Bayesian methods for multivariate modeling of pleiotropic SNP associations and genetic risk prediction. Front Genet. 2012;3:176.
44. Lusis AJ, Fogelman AM, Fonarow GC. Genetic basis of atherosclerosis: part I: new genes and pathways. Circulation. 2004;110:1868-1873. (Pubitemid 39299231)
45. Verschuren WM, Blokstra A, Picavet HS, Smit HA. Cohort profile: the Doetinchem Cohort Study. Int J Epidemiol. 2008;37:1236-1241.
46. Lu Y, Feskens EJ, Boer JM, Imholz S, Verschuren WM, Wijmenga C, et al. Exploring genetic determinants of plasma total cholesterol levels and their predictive value in a longitudinal study. Atherosclerosis. 2010;213:200-205.
47. Belsky DW, Moffitt TE, Sugden K, Williams B, Houts R, McCarthy J, et al. Development and evaluation of a genetic risk score for obesity. Biodemography Soc Biol. 2013;59:85-100.
48. Folsom AR, Chambless LE, Ballantyne CM, Coresh J, Heiss G, Wu KK, et al. An assessment of incremental coronary risk prediction using C- reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med. 2006;166:1368-1373. (Pubitemid 44036348)
49. Kooperberg C, LeBlanc M, Obenchain V. Risk prediction using genome- wide association studies. Genet Epidemiol. 2010;34:643-652.
50. Yang J, Manolio TA, Pasquale LR, Boerwinkle E, Caporaso N, Cunningham JM, et al. Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet. 2011;43:519-525.